Abbott India has partnered Novo Nordisk to market semaglutide under the Extensior brand, aiming to tap rising demand for advanced diabetes therapies in one of the world’s fastest-growing markets.
Abbott India has partnered Novo Nordisk to market semaglutide under the Extensior brand, aiming to tap rising demand for advanced diabetes therapies in one of the world’s fastest-growing markets.